The DxN Veris was recently launched as a CE-marked product with a menu of viral load tests, and will launch in a few years in the US with STD and HAI assays.
The new assay uses high-resolution melt curve analysis to detect variations in genes that lead some people to spontaneously clear hepatitis C viral infections.